Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells

Cancer

Volumn 119, Issue 2, 2013, Pages 304-312

  Zhao, Junhong ^a   Liang, Qiaoyi ^a   Cheung, Kin Fai ^a   Kang, Wei ^b   Lung, Raymond W M ^b   Tong, Joanna H M ^b   To, Ka Fai ^b   Sung, Joseph J Y ^a   Yu, Jun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

epigenome; Epstein Barr virus; gastric cancer; promoter methylation; tumor suppressor gene

Indexed keywords

CELL ADHESION MOLECULE; DNA METHYLTRANSFERASE 3B; INTERLEUKIN 15 RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; SCAVENGER RECEPTOR F; SOMATOSTATIN RECEPTOR 1; WNT PROTEIN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; DNA MICROARRAY; ENZYME ACTIVATION; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IL15RA GENE; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; LMP2A GENE; MDGA2 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REC8 GENE; SCARF2 GENE; SSTR1 GENE; STOMACH CANCER; UPREGULATION; VIRUS GENE; VIRUS IDENTIFICATION; WNT SIGNALING PATHWAY;

CELL CYCLE PROTEINS; CELL LINE, TUMOR; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; ENZYME ACTIVATION; EPIGENESIS, GENETIC; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; PROMOTER REGIONS, GENETIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, INTERLEUKIN-15; RECEPTORS, SOMATOSTATIN; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS; VIRAL MATRIX PROTEINS;

EID: 84872087715     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27724     Document Type: Article

References (23)

1. Deyrup AT,. Epstein-Barr virus-associated epithelial and mesenchymal neoplasms. Hum Pathol. 2008; 39: 473-483.
2. Thompson MP, Kurzrock R,. Epstein-Barr virus and cancer. Clin Cancer Res. 2004; 10: 803-821.
3. Lee JH, Kim SH, Han SH, An JS, Lee ES, Kim YS,. Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis. J Gastroenterol Hepatol. 2009; 24: 354-365.
4. Takada K,. Epstein-Barr virus and gastric carcinoma. Mol Pathol. 2000; 53: 255-261.
5. Fukayama M, Hino R, Uozaki H,. Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma. Cancer Sci. 2008; 99: 1726-1733.
6. Tao Q, Young LS, Woodman CB, Murray PG,. Epstein-Barr virus (EBV) and its associated human cancers-genetics, epigenetics, pathobiology and novel therapeutics. Front Biosci. 2006; 11: 2672-2713.
7. Hino R, Uozaki H, Murakami N, et al. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res. 2009; 69: 2766-2774.
8. Ushiku T, Chong JM, Uozaki H, et al. p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer. 2007; 120: 60-66.
9. Geddert H, zur Hausen A, Gabbert HE, Sarbia M,. EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1. Cell Oncol (Dordr). 2011; 34: 209-214.
10. Sudo M, Chong JM, Sakuma K, et al. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer. 2004; 109: 194-199.
11. Hino R, Uozaki H, Inoue Y, et al. Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent. Cancer Res. 2008; 68: 1427-1435.
12. Delecluse HJ, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W,. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A. 1998; 95: 8245-8250.
13. Lung RW, Tong JH, Sung YM, et al. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia. 2009; 11: 1174-1184.
14. Teschendorff AE, Menon U, Gentry-Maharaj A, et al. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res. 2010; 20: 440-446.
15. Zhao J, Jin H, Cheung KF, et al. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer. Cancer. 2012; 118: 924-936.
16. Matsusaka K, Kaneda A, Nagae G, et al. Classification of epstein-barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. Cancer Res. 2011; 71: 7187-7197.
17. Park J, Kang SI, Lee SY, et al. Tumor suppressor ras association domain family 5 (RASSF5/NORE1) mediates death receptor ligand-induced apoptosis. J Biol Chem. 2010; 285: 35029-35038.
18. Zhao Y, Yang J, Liao W, et al. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat Cell Biol. 2010; 12: 665-675.
19. Lévy P, Ripoche H, Laurendeau I, et al. Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1. Clin Cancer Res. 2007; 13: 398-407.
20. Chan AY, Coniglio SJ, Chuang YY, et al. Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. Oncogene. 2005; 24: 7821-7829.
21. Kourlas PJ, Strout MP, Becknell B, et al. Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci U S A. 2000; 97: 2145-2150.
22. van Beek J, zur Hausen A, Klein Kranenbarg E, et al. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol. 2004; 22: 664-670.
23. Mani S, Herceg Z,. DNA demethylating agents and epigenetic therapy of cancer. Adv Genet. 2010; 70: 327-340.